A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 21, Issue 8, Pages 1337-1347
Publisher
American Association for Cancer Research (AACR)
Online
2022-08-02
DOI
10.1158/1535-7163.mct-21-0285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
- (2020) Ruo-Yu Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Angiogenesis Inhibition in Prostate Cancer: An Update
- (2020) Chandrani Sarkar et al. Cancers
- Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
- (2019) Xiangyu Zhang Cancer Communications
- Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells
- (2018) Dariusz Zakrzewicz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy
- (2018) Luyao Wang et al. Nanoscale
- Translational models of prostate cancer bone metastasis
- (2018) Richard B. Berish et al. Nature Reviews Urology
- TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer
- (2018) Channing Paller et al. PROSTATE
- Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells
- (2018) Karen A. Cavassani et al. Cancer Medicine
- AB0071 Alpha-Enolase Expression on The Cell Surface of Osteoclast Precursors Plays A Positive Role in Osteoclastogenesis of Monocyte/macrophage in Rheumatoid Arthritis
- (2016) J.H. Shin et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer
- (2016) X. Chen et al. CLINICAL CANCER RESEARCH
- STIM1/ORAI1-mediated Ca2+Influx Regulates Enolase-1 Exteriorization
- (2015) Miroslava Didiasova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells
- (2015) Moitza Principe et al. Oncotarget
- Enolase-1 is a therapeutic target in endometrial carcinoma
- (2015) Mengyang Zhao et al. Oncotarget
- An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo
- (2015) Shafaat A. Rabbani et al. NEOPLASIA
- Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
- (2014) B. Gurel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
- (2014) Ye Song et al. Molecular Cancer
- Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade
- (2014) Satoshi Nishizawa et al. SpringerPlus
- Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target
- (2013) Kuan-Chung Hsiao et al. PLoS One
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
- (2012) Àngels Díaz-Ramos et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
- (2012) Xuan Huang et al. Journal of Hematology & Oncology
- -Enolase Expressed on the Surfaces of Monocytes and Macrophages Induces Robust Synovial Inflammation in Rheumatoid Arthritis
- (2012) S. Bae et al. JOURNAL OF IMMUNOLOGY
- Estrogen Promotes Prostate Cancer Cell Migration via Paracrine Release of ENO1 from Stromal Cells
- (2012) Lin Yu et al. MOLECULAR ENDOCRINOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- α-enolase: a promising therapeutic and diagnostic tumor target
- (2011) Michela Capello et al. FEBS Journal
- Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast Function
- (2011) Yosuke Kanno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Local treatment of metastatic cancer—killing the seed or disturbing the soil?
- (2011) Scott C. Morgan et al. Nature Reviews Clinical Oncology
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Tumor necrosis factor and cancer, buddies or foes?
- (2009) Xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung
- (2009) M. Wygrecka et al. BLOOD
- Inflammation, cancer, and bone loss
- (2009) Yousef Abu-Amer CURRENT OPINION IN PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started